Ingalls Hospital is a clinical research site located in Harvey, Illinois, United States 60426-3558.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Ingalls Hospital has participated in 5 clinical trials with 1 currently active.
Therapeutic areas: Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, Stage IIIB Non-Small Cell Lung Cancer.
Sponsors: EMD Serono Research & Development Institute, Inc., Synta Pharmaceuticals Corp., Procter and Gamble.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Ingalls Hospital has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Ingalls Hospital has 5 clinical trials on record, with 1 currently active. Their work covers Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, Stage IIIB Non-Small Cell Lung Cancer.
Yes — Ingalls Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.